Literature DB >> 2297457

Biliary elimination of non-steroidal anti-inflammatory drugs in patients.

H T Schneider1, B Nuernberg, K Dietzel, K Brune.   

Abstract

In view of evidence in animals that enterohepatic recirculation of non-steroidal anti-inflammatory drugs contributes to small intestinal mucosal damage we have investigated the extent of biliary elimination of three nonsteroidals. Ibuprofen (n = 3), diclofenac (n = 2) and indomethacin (n = 3) were given to six patients with a percutaneous transhepatic cholangiodrainage placed in the bile duct system. One patient received all three drugs. The mean biliary elimination of ibuprofen was 0.82% of the given dose compared with 50.41% urinary excretion. When diclofenac or indomethacin was administered 4.62% and 6.40% of the dose were found in bile, whereas 34.73% and 32.22% (means) were recovered from urine, respectively. The mean percentage eliminated in bile as unchanged drug and active phase II metabolites was 0.15% for ibuprofen, 1.09% for diclofenac and 5.02% for indomethacin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297457      PMCID: PMC1380072          DOI: 10.1111/j.1365-2125.1990.tb03613.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

Review 1.  Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs.

Authors:  R K Verbeeck
Journal:  J Rheumatol Suppl       Date:  1988-10

2.  High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids.

Authors:  G Geisslinger; K Dietzel; D Loew; O Schuster; G Rau; G Lachmann; K Brune
Journal:  J Chromatogr       Date:  1989-06-30

3.  Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics.

Authors:  M Levy; D R Miller; D W Kaufman; V Siskind; P Schwingl; L Rosenberg; B Strom; S Shapiro
Journal:  Arch Intern Med       Date:  1988-02

4.  Enterohepatic circulation of indomethacin and its role in intestinal irritation.

Authors:  D E Duggan; K F Hooke; R M Noll; K C Kwan
Journal:  Biochem Pharmacol       Date:  1975-10-01       Impact factor: 5.858

5.  FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugs.

Authors:  H E Paulus
Journal:  Arthritis Rheum       Date:  1985-10

6.  High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids.

Authors:  J Godbillon; S Gauron; J P Metayer
Journal:  J Chromatogr       Date:  1985-02-27

7.  High-performance liquid chromatographic method for the determination of indomethacin and its two primary metabolites in urine.

Authors:  P C Smith; L Z Benet
Journal:  J Chromatogr       Date:  1984-03-09

8.  Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.

Authors:  M J Langman; L Morgan; A Worrall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02
  8 in total
  14 in total

1.  Pharmacokinetics of diflunisal in patients.

Authors:  B Nuernberg; G Koehler; K Brune
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 2.  Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs)?

Authors:  K Brune
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

4.  Pain management for dentists: the role of ibuprofen.

Authors:  Alessandro Pozzi; Luca Gallelli
Journal:  Ann Stomatol (Roma)       Date:  2012-04-15

5.  Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F1 alpha and leukotriene B4 level in relation to gastroenteropathy.

Authors:  A Uçar; S D Sak; M Melli
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

6.  Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved.

Authors:  W S Beck; H T Schneider; K Dietzel; B Nuernberg; K Brune
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 7.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

8.  In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats.

Authors:  O M Laudanno; J A Cesolari; J Esnarriaga; P San Miguel; O A Bedini
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 9.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

10.  Non-steroidal anti-inflammatory drugs and stercoral perforation of the colon.

Authors:  J Hollingworth; J Alexander-Williams
Journal:  Ann R Coll Surg Engl       Date:  1991-11       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.